Protein aggregation in bacteria: The thin boundary between functionality and toxicity

Microbiology (United Kingdom)

Volumn 159, Issue PART 9, 2013, Pages 1795-1806

  Bednarska, Natalia G ^a   Schymkowitz, Joost ^b,c   Rousseau, Frederic ^b,c   Van Eldere, Johan ^a  

^a REGA INSTITUTE   (Belgium)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; BACTERIAL PROTEIN; PROTEASOME;

ALZHEIMER DISEASE; BACTERIAL CELL; BACTERIAL MEMBRANE; BACTERIAL VIABILITY; DEGENERATIVE DISEASE; ENVIRONMENTAL FACTOR; HUNTINGTON CHOREA; LIPID PEROXIDATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN HOMEOSTASIS; PROTEIN SYNTHESIS; REVIEW;

EID: 84883443658     PISSN: 13500872     EISSN: 14652080     Source Type: Journal    
DOI: 10.1099/mic.0.069575-0     Document Type: Review

References (94)

1. Ami, D., Natalello, A., Schultz, T., Gatti-Lafranconi, P., Lotti, M., Doglia, S. M. & de Marco, A. (2009). Effects of recombinant protein misfolding and aggregation on bacterial membranes. Biochim Biophys Acta 1794, 263-269.
2. Amijee, H., Madine, J., Middleton, D. A. & Doig, A. J. (2009). Inhibitors of protein aggregation and toxicity. Biochem Soc Trans 37, 692-696.
3. Balch, W. E., Morimoto, R. I., Dillin, A. & Kelly, J. W. (2008). Adapting proteostasis for disease intervention. Science 319, 916-919.
4. Balguerie, A., Dos Reis, S., Ritter, C., Chaignepain, S., Coulary-Salin, B., Forge, V., Bathany, K., Lascu, I., Schmitter, J. M. & other authors (2003). Domain organization and structure-function relationship of the HET-s prion protein of Podospora anserina. EMBO J 22, 2071-2081.
5. Beerten, J., Schymkowitz, J. & Rousseau, F. (2012). Aggregation prone regions and gatekeeping residues in protein sequences. Curr Top Med Chem 12, 2470-2478.
6. Bence, N. F., Sampat, R. M. & Kopito, R. R. (2001). Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292, 1552-1555.
7. Benilova, I., Karran, E. & De Strooper, B. (2012). The toxic Ab oligomer and Alzheimer's disease: an emperor in need of clothes. Nat Neurosci 15, 349-357.
8. Berge, A., Kihlberg, B.-M., Sjöholm, A. G. & Björck, L. (1997). Streptococcal protein H forms soluble complement-activating complexes with IgG, but inhibits complement activation by IgG-coated targets. J Biol Chem 272, 20774-20781.
9. Bieler, S., Estrada, L., Lagos, R., Baeza, M., Castilla, J. & Soto, C. (2005). Amyloid formation modulates the biological activity of a bacterial protein. J Biol Chem 280, 26880-26885.
10. Brötz-Oesterhelt, H., Beyer, D., Kroll, H.-P., Endermann, R., Ladel, C., Schroeder, W., Hinzen, B., Raddatz, S., Paulsen, H. & other authors (2005). Dysregulation of bacterial proteolytic machinery by a new class of antibiotics. Nat Med 11, 1082-1087.
11. Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C. M. & Stefani, M. (2002). Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416, 507-511.
12. Capstick, D. S., Jomaa, A., Hanke, C., Ortega, J. & Elliot, M. A. (2011). Dual amyloid domains promote differential functioning of the chaplin proteins during Streptomyces aerial morphogenesis. Proc Natl Acad Sci U S A 108, 9821-9826.
13. Carrió, M. M. & Villaverde, A. (2003). Role of molecular chaperones in inclusion body formation. FEBS Lett 537, 215-221.
14. Carrió, M. M., Cubarsi, R. & Villaverde, A. (2000). Fine architecture of bacterial inclusion bodies. FEBS Lett 471, 7-11.
15. Carrió, M., González-Montalbán, N., Vera, A., Villaverde, A. & Ventura, S. (2005). Amyloid-like properties of bacterial inclusion bodies. J Mol Biol 347, 1025-1037.
16. Castillo, V., Graña-Montes, R. & Ventura, S. (2011). The aggregation properties of Escherichia coli proteins associated with their cellular abundance. Biotechnol J 6, 752-760.
17. Chaussee, M. S., Phillips, E. R. & Ferretti, J. J. (1997). Temporal production of streptococcal erythrogenic toxin B (streptococcal cysteine proteinase) in response to nutrient depletion. Infect Immun 65, 1956-1959.
18. Cheng, L., Naumann, T. A., Horswill, A. R., Hong, S.-J., Venters, B. J., Tomsho, J. W., Benkovic, S. J. & Keiler, K. C. (2007). Discovery of antibacterial cyclic peptides that inhibit the ClpXP protease. Protein Sci 16, 1535-1542.
19. Chiti, F. & Dobson, C. M. (2009). Amyloid formation by globular proteins under native conditions. Nat Chem Biol 5, 15-22.
20. Choi, Y.-G., Kim, J.-I., Lee, H.-P., Jin, J.-K., Choi, E.-K., Carp, R. I. & Kim, Y.-S. (2000). Induction of heme oxygenase-1 in the brains of scrapie-infected mice. Neurosci Lett 289, 173-176.
21. de Groot, N. S. & Ventura, S. (2010). Protein aggregation profile of the bacterial cytosol. PLoS ONE 5, e9383.
22. de Groot, N. S., Sabate, R. & Ventura, S. (2009). Amyloids in bacterial inclusion bodies. Trends Biochem Sci 34, 408-416.
23. Demuro, A., Mina, E., Kayed, R., Milton, S. C., Parker, I. & Glabe, C. G. (2005). Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J Biol Chem 280, 17294-17300.
24. Dominguez, D. C. (2004). Calcium signalling in bacteria. Mol Microbiol 54, 291-297.
25. Dougan, D. A., Mogk, A. & Bukau, B. (2002). Protein folding and degradation in bacteria: to degrade or not to degrade? That is the question. Cell Mol Life Sci 59, 1607-1616.
26. DuBay, K. F., Pawar, A. P., Chiti, F., Zurdo, J., Dobson, C. M. & Vendruscolo, M. (2004). Prediction of the absolute aggregation rates of amyloidogenic polypeptide chains. J Mol Biol 341, 1317-1326.
27. Dukan, S. & Nyström, T. (1998). Bacterial senescence: stasis results in increased and differential oxidation of cytoplasmic proteins leading to developmental induction of the heat shock regulon. Genes Dev 12, 3431-3441.
28. Fink, A. L. (1998). Protein aggregation: folding aggregates, inclusion bodies and amyloid. Folding Des 3, R9-R23.
29. Fowler, D. M., Koulov, A. V., Balch, W. E. & Kelly, J. W. (2007). Functional amyloid-from bacteria to humans. Trends Biochem Sci 32, 217-224.
30. Frees, D., Qazi, S. N. A., Hill, P. J. & Ingmer, H. (2003). Alternative roles of ClpX and ClpP in Staphylococcus aureus stress tolerance and virulence. Mol Microbiol 48, 1565-1578.
31. Frick, I. M., Mörgelin, M. & Björck, L. (2000). Virulent aggregates of Streptococcus pyogenes are generated by homophilic protein-protein interactions. Mol Microbiol 37, 1232-1247.
32. García-Fruitós, E., González-Montalbán, N., Morell, M., Vera, A., Ferraz, R. M., Arís, A., Ventura, S. & Villaverde, A. (2005). Aggregation as bacterial inclusion bodies does not imply inactivation of enzymes and fluorescent proteins. Microb Cell Fact 4, 27.
33. Garland, W. J. & Buckley, J. T. (1988). The cytolytic toxin aerolysin must aggregate to disrupt erythrocytes, and aggregation is stimulated by human glycophorin. Infect Immun 56, 1249-1253.
34. Garrity, S. J., Sivanathan, V., Dong, J., Lindquist, S. & Hochschild, A. (2010). Conversion of a yeast prion protein to an infectious form in bacteria. Proc Natl Acad Sci U S A 107, 10596-10601.
35. Glabe, C. G. (2006). Common mechanisms of amyloid oligomer pathogenesis in degenerative disease. Neurobiol Aging 27, 570-575.
36. Green, J. D., Kreplak, L., Goldsbury, C., Li Blatter, X., Stolz, M., Cooper, G. S., Seelig, A., Kistler, J. & Aebi, U. (2004). Atomic force microscopy reveals defects within mica supported lipid bilayers induced by the amyloidogenic human amylin peptide. J Mol Biol 342, 877-887.
37. Gsponer, J. & Babu, M. M. (2012). Cellular strategies for regulating functional and nonfunctional protein aggregation. Cell Rep 2, 1425-1437.
38. Guentchev, M., Voigtländer, T., Haberler, C., Groschup, M. H. & Budka, H. (2000). Evidence for oxidative stress in experimental prion disease. Neurobiol Dis 7, 270-273.
39. Guisbert, E., Herman, C., Lu, C. Z. & Gross, C. A. (2004). A chaperone network controls the heat shock response in E. coli. Genes Dev 18, 2812-2821.
40. Hartl, F. U., Bracher, A. & Hayer-Hartl, M. (2011). Molecular chaperones in protein folding and proteostasis. Nature 475, 324-332.
41. Herbaud, M.-L., Guiseppi, A., Denizot, F., Haiech, J. & Kilhoffer, M.-C. (1998). Calcium signalling in Bacillus subtilis. Biochim Biophys Acta 1448, 212-226.
42. Hirakura, Y., Azimov, R., Azimova, R. & Kagan, B. L. (2000). Polyglutamine-induced ion channels: a possible mechanism for the neurotoxicity of Huntington and other CAG repeat diseases. J Neurosci Res 60, 490-494.
43. Hotze, E. M., Heuck, A. P., Czajkowsky, D. M., Shao, Z., Johnson, A. E. & Tweten, R. K. (2002). Monomer-monomer interactions drive the prepore to pore conversion of a β-barrel-forming cholesteroldependent cytolysin. J Biol Chem 277, 11597-11605.
44. Hyun, D.-H., Lee, M., Hattori, N., Kubo, S.-I., Mizuno, Y., Halliwell, B. & Jenner, P. (2002). Effect of wild-type or mutant Parkin on oxidative damage, nitric oxide, antioxidant defenses, and the proteasome. J Biol Chem 277, 28572-28577.
45. Jahn, T. R. & Radford, S. E. (2005). The Yin and Yang of protein folding. FEBS J 272, 5962-5970.
46. Kagan, B. L., Hirakura, Y., Azimov, R. & Azimova, R. (2001). The channel hypothesis of Huntington's disease. Brain Res Bull 56, 281-284.
47. Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W. & Glabe, C. G. (2003). Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486-489.
48. Kragol, G., Lovas, S., Varadi, G., Condie, B. A., Hoffmann, R. & Otvos, L., Jr (2001). The antibacterial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaperone-assisted protein folding. Biochemistry 40, 3016-3026.
49. Kress, W., Maglica, Ž. & Weber-Ban, E. (2009). Clp chaperoneproteases: structure and function. Res Microbiol 160, 618-628.
50. Krüger, E., Witt, E., Ohlmeier, S., Hanschke, R. & Hecker, M. (2000). The Clp proteases of Bacillus subtilis are directly involved in degradation of misfolded proteins. J Bacteriol 182, 3259-3265.
51. Lashuel, H. A. & Lansbury, P. T., Jr (2006). Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins? Q Rev Biophys 39, 167-201.
52. Liberek, K., Lewandowska, A. & Zietkiewicz, S. (2008). Chaperones in control of protein disaggregation. EMBO J 27, 328-335.
53. Lin, G., Li, D., de Carvalho, L. P. S., Deng, H., Tao, H., Vogt, G., Wu, K., Schneider, J., Chidawanyika, T. & other authors (2009). Inhibitors selective for mycobacterial versus human proteasomes. Nature 461, 621-626.
54. Lindner, A. B., Madden, R., Demarez, A., Stewart, E. J. & Taddei, F. (2008). Asymmetric segregation of protein aggregates is associated with cellular aging and rejuvenation. Proc Natl Acad Sci U S A 105, 3076-3081.
55. Ling, J., Cho, C., Guo, L. T., Aerni, H. R., Rinehart, J. & Söll, D. (2012). Protein aggregation caused by aminoglycoside action is prevented by a hydrogen peroxide scavenger. Mol Cell 48, 713-722.
56. Maisonneuve, E., Fraysse, L., Moinier, D. & Dukan, S. (2008a). Existence of abnormal protein aggregates in healthy Escherichia coli cells. J Bacteriol 190, 887-893.
57. Maisonneuve, E., Fraysse, L., Lignon, S., Capron, L. & Dukan, S. (2008b). Carbonylated proteins are detectable only in a degradationresistant aggregate state in Escherichia coli. J Bacteriol 190, 6609-6614.
58. Makin, O. S., Atkins, E., Sikorski, P., Johansson, J. & Serpell, L. C. (2005). Molecular basis for amyloid fibril formation and stability. Proc Natl Acad Sci U S A 102, 315-320.
59. Markossian, K. A. & Kurganov, B. I. (2004). Protein folding, misfolding, and aggregation. Formation of inclusion bodies and aggresomes. Biochemistry (Moscow) 69, 971-984.
60. Martínez-Alonso, M., González-Montalbán, N., García-Fruitós, E. & Villaverde, A. (2009). Learning about protein solubility from bacterial inclusion bodies. Microb Cell Fact 8, 4.
61. Maurer-Stroh, S., Debulpaep, M., Kuemmerer, N., Lopez de la Paz, M., Martins, I. C., Reumers, J., Morris, K. L., Copland, A., Serpell, L. & other authors (2010). Exploring the sequence determinants of amyloid structure using position-specific scoring matrices. Nat Methods 7, 237-242.
62. Menozzi, F. D., Boucher, P. E., Riveau, G., Gantiez, C. & Locht, C. (1994). Surface-associated filamentous hemagglutinin induces autoagglutination of Bordetella pertussis. Infect Immun 62, 4261-4269.
63. Menozzi, F. D., Rouse, J. H., Alavi, M., Laude-Sharp, M., Muller, J., Bischoff, R., Brennan, M. J. & Locht, C. (1996). Identification of a heparin-binding hemagglutinin present in mycobacteria. J Exp Med 184, 993-1001.
64. Merino, N., Toledo-Arana, A., Vergara-Irigaray, M., Valle, J., Solano, C., Calvo, E., Lopez, J. A., Foster, T. J., Penadés, J. R. & Lasa, I. (2009). Protein A-mediated multicellular behavior in Staphylococcus aureus. J Bacteriol 191, 832-843.
65. Milhavet, O. & Lehmann, S. (2002). Oxidative stress and the prion protein in transmissible spongiform encephalopathies. Brain Res Brain Res Rev 38, 328-339.
66. Mogk, A., Mayer, M. P. & Deuerling, E. (2002). Mechanisms of protein folding: molecular chaperones and their application in biotechnology. ChemBioChem 3, 807-814.
67. Monoi, H. (1995). New tubular single-stranded helix of poly-Lamino acids suggested by molecular mechanics calculations: I. Homopolypeptides in isolated environments. Biophys J 69, 1130-1141.
68. Morgan, G. J., Giannini, S., Hounslow, A. M., Craven, C. J., Zerovnik, E., Turk, V., Waltho, J. P. & Staniforth, R. A. (2008). Exclusion of the native α-helix from the amyloid fibrils of a mixed a/b protein. J Mol Biol 375, 487-498.
69. Muchowski, P. J. & Wacker, J. L. (2005). Modulation of neurodegeneration by molecular chaperones. Nat Rev Neurosci 6, 11-22.
70. Nelson, R., Sawaya, M. R., Balbirnie, M., Madsen, A. O., Riekel, C., Grothe, R. & Eisenberg, D. (2005). Structure of the cross-b spine of amyloid-like fibrils. Nature 435, 773-778.
71. Okumura, S., Saitoh, H., Ishikawa, T., Inouye, K. & Mizuki, E. (2011). Mode of action of parasporin-4, a cytocidal protein from Bacillus thuringiensis. Biochim Biophys Acta 1808, 1476-1482.
72. Olzscha, H., Schermann, S. M., Woerner, A. C., Pinkert, S., Hecht, M. H., Tartaglia, G. G., Vendruscolo, M., Hayer-Hartl, M., Hartl, F. U. & Vabulas, R. M. (2011). Amyloid-like aggregates sequester numerous metastable proteins with essential cellular functions. Cell 144, 67-78.
73. Ono, K., Takahashi, R., Ikeda, T. & Yamada, M. (2012). Cross-seeding effects of amyloid β-protein and α-synuclein. J Neurochem 122, 883-890.
74. Otzen, D. & Nielsen, P. H. (2008). We find them here, we find them there: functional bacterial amyloid. Cell Mol Life Sci 65, 910-927.
75. Quist, A., Doudevski, I., Lin, H., Azimova, R., Ng, D., Frangione, B., Kagan, B., Ghiso, J. & Lal, R. (2005). Amyloid ion channels: a common structural link for protein-misfolding disease. Proc Natl Acad Sci U S A 102, 10427-10432.
76. Reumers, J., Maurer-Stroh, S., Schymkowitz, J. & Rousseau, F. (2009). Protein sequences encode safeguards against aggregation. Hum Mutat 30, 431-437.
77. Robertson, G. T., Ng, W.-L., Gilmour, R. & Winkler, M. E. (2003). Essentiality of clpX, but not clpP, clpL, clpC, or clpE, in Streptococcus pneumoniae R6. J Bacteriol 185, 2961-2966.
78. Romero, D., Aguilar, C., Losick, R. & Kolter, R. (2010). Amyloid fibers provide structural integrity to Bacillus subtilis biofilms. Proc Natl Acad Sci U S A 107, 2230-2234.
79. Rousseau, F., Schymkowitz, J. & Serrano, L. (2006a). Protein aggregation and amyloidosis: confusion of the kinds? Curr Opin Struct Biol 16, 118-126.
80. Rousseau, F., Serrano, L. & Schymkowitz, J. W. (2006b). How evolutionary pressure against protein aggregation shaped chaperone specificity. J Mol Biol 355, 1037-1047.
81. Sarell, C. J., Woods, L. A., Su, Y., Debelouchina, G. T., Ashcroft, A. E., Griffin, R. G., Stockley, P. G. & Radford, S. E. (2013). Expanding the repertoire of amyloid polymorphs by co-polymerization of related protein precursors. J Biol Chem 288, 7327-7337.
82. Sawyer, E. B., Claessen, D., Haas, M., Hurgobin, B. & Gras, S. L. (2011). The assembly of individual chaplin peptides from Streptomyces coelicolor into functional amyloid fibrils. PLoS ONE 6, e18839.
83. Schlieker, C., Bukau, B. & Mogk, A. (2002). Prevention and reversion of protein aggregation by molecular chaperones in the E. coli cytosol: implications for their applicability in biotechnology. J Biotechnol 96, 13-21.
84. Steffan, J. S., Kazantsev, A., Spasic-Boskovic, O., Greenwald, M., Zhu, Y. Z., Gohler, H., Wanker, E. E., Bates, G. P., Housman, D. E. & Thompson, L. M. (2000). The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc Natl Acad Sci U S A 97, 6763-6768.
85. Stöver, A. G. & Driks, A. (1999). Secretion, localization, and antibacterial activity of TasA, a Bacillus subtilis spore-associated protein. J Bacteriol 181, 1664-1672.
86. Su, C.-Y., Chong, K.-Y., Edelstein, K., Lille, S., Khardori, R. & Lai, C.-C. (1999). Constitutive hsp70 attenuates hydrogen peroxideinduced membrane lipid peroxidation. Biochem Biophys Res Commun 265, 279-284.
87. Tartaglia, G. G. & Vendruscolo, M. (2009). Correlation between mRNA expression levels and protein aggregation propensities in subcellular localisations. Mol Biosyst 5, 1873-1876.
88. Tyedmers, J., Mogk, A. & Bukau, B. (2010). Cellular strategies for controlling protein aggregation. Nat Rev Mol Cell Biol 11, 777-788.
89. Ventura, S. & Villaverde, A. (2006). Protein quality in bacterial inclusion bodies. Trends Biotechnol 24, 179-185.
90. Vera, A., Arís, A., Carrió, M., González-Montalbán, N. & Villaverde, A. (2005). Lon and ClpP proteases participate in the physiological disintegration of bacterial inclusion bodies. J Biotechnol 119, 163-171.
91. Villa, R., Lotti, M. & Gatti-Lafranconi, P. (2009). Components of the E. coli envelope are affected by and can react to protein over-production in the cytoplasm. Microb Cell Fact 8, 32.
92. Wang, X., Smith, D. R., Jones, J. W. & Chapman, M. R. (2007). In vitro polymerization of a functional Escherichia coli amyloid protein. J Biol Chem 282, 3713-3719.
93. Wang, L., Maji, S. K., Sawaya, M. R., Eisenberg, D. & Riek, R. (2008). Bacterial inclusion bodies contain amyloid-like structure. PLoS Biol 6, e195.
94. Wang, X., Zhou, Y., Ren, J. J., Hammer, N. D. & Chapman, M. R. (2010). Gatekeeper residues in the major curlin subunit modulate bacterial amyloid fiber biogenesis. Proc Natl Acad Sci U S A 107, 163-168.